Accelerate the Biomarker Validation, Clinical Development & Market Adoption of the Next Generation of Targeted Therapies & Diagnostics
The 7th Annual World CDx Boston Summit 2016 will once again provide the industry-defining platform for drug, diagnostic and tech developers to accelerate the progression of targeted-therapies and diagnostics from biomarker validation, through the clinic and to stratified patient populations.
Discover the latest end to end case studies demonstrating how to maximize the added value of precision medicine and tackle the cost-benefit analysis associated with embarking on a diagnostic strategy. Be part of critical discussions around the role of biomarkers and diagnostics in immuno-oncology, demonstrating clinical utility with liquid biopsies, securing evidence-based reimbursement and more.
“World CDx was a fantastic event both in terms of the science and the networking opportunities."
- Oscar Puig, Biomarker Leader, Oncology, Roche